Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in health harms due to cannabis following legalisation of non‐medical cannabis in Canada in context of cannabis commercialisation: A scoping review
Daniel T. Myran, Sameer Imtiaz, Lauren Konikoff, et al.
Drug and Alcohol Review (2022) Vol. 42, Iss. 2, pp. 277-298
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Marco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
BMJ (2023), pp. e072348-e072348
Open Access | Times Cited: 121
The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 19
Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T. Myran, Michael Pugliese, Lyndsay D. Harrison, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457868-e2457868
Open Access | Times Cited: 4
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
Daniel T. Myran, Michael Pugliese, André J. McDonald, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457852-e2457852
Open Access | Times Cited: 3
Access to legal cannabis market in Canada over the four years following non‐medical cannabis legalisation
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 31
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 25
Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis
Daniel T. Myran, Michael Pugliese, Rhiannon Roberts, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4251-4260
Closed Access | Times Cited: 24
Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
Benedikt Fischer, Didier Jutras‐Aswad, Wayne Hall
Canadian Medical Association Journal (2023) Vol. 195, Iss. 39, pp. E1351-E1353
Open Access | Times Cited: 23
Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue
Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, et al.
Substance Abuse Treatment Prevention and Policy (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
The ‘ban’ for public health that wasn't? Views and impressions on cannabis retail promotion/advertising realities amidst legalization policy in Canada
Benedikt Fischer
International Journal of Drug Policy (2024) Vol. 131, pp. 104294-104294
Closed Access | Times Cited: 4
Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments
Benedikt Fischer, Tessa Robinson, Didier Jutras‐Aswad
Journal of Public Health Policy (2025)
Closed Access
On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices
Felicia Tassone, Patricia Di Ciano, Yuxin Liu, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis
Hudson Reddon, Stephanie Lake, M. Eugenia Socías, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104113-104113
Closed Access | Times Cited: 10
Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 853-862
Open Access | Times Cited: 3
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization
Laurent Perrault‐Sequeira, Michael Pugliese, Rachael MacDonald‐Spracklin, et al.
American Journal on Addictions (2025)
Open Access
Exploring the role of primary regulation differences for cannabis legalization outcomes – preliminary data from two Canadian provinces
Tessa Robinson, Didier Jutras‐Aswad, Benedikt Fischer
Drugs Education Prevention and Policy (2024), pp. 1-7
Closed Access | Times Cited: 3
Primary crime-related outcome indicators associated with recreational cannabis legalization: a comprehensive literature and data review
Benedikt Fischer, Tessa Robinson, Hans‐Jörg Albrecht
Crime Law and Social Change (2024) Vol. 82, Iss. 3, pp. 685-715
Closed Access | Times Cited: 2
Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada
Kelly K. Anderson, Rebecca Rodrigues, Britney Le, et al.
International Journal of Drug Policy (2023) Vol. 123, pp. 104285-104285
Closed Access | Times Cited: 4
Cannabis legalization and driving under the influence of cannabis and driving under the influence of alcohol among adult and adolescent drivers in Ontario, Canada (2001–2019)
Sameer Imtiaz, Yeshambel T. Nigatu, Farihah Ali, et al.
Drug and Alcohol Dependence (2023) Vol. 255, pp. 111060-111060
Closed Access | Times Cited: 4
Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
Stephen D.S. McCarthy, Jennifer Xiao, Michael Pugliese, et al.
The Lancet Regional Health - Americas (2024) Vol. 36, pp. 100815-100815
Open Access | Times Cited: 1
Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada
José Ignacio Nazif‐Muñoz, Pablo Martínez, Christophe Huỳnh, et al.
Addiction (2024) Vol. 119, Iss. 10, pp. 1784-1791
Open Access | Times Cited: 1
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers
Toula Kourgiantakis, Angie Hamilton, Christine Tait, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Should cannabis self-cultivation be part of a public health‒oriented legalization policy framework?
Benedikt Fischer, Tessa Robinson
Can J Public Health (2024) Vol. 115, Iss. 5, pp. 784-788
Closed Access
Nonmedical cannabis legalization policy in Canada: Has commercialization been a pivotal mistake for public health?
Benedikt Fischer, Wayne Hall, Didier Jutras‐Aswad, et al.
World Medical & Health Policy (2024)
Open Access
Response to Smyth & McCarron: Increases in cannabis‐attributable emergency department visits during different phases of the pre‐ and post‐legalization period are multi‐factorial
Daniel T. Myran, Michael Pugliese, Peter Tanuseputro, et al.
Addiction (2023) Vol. 118, Iss. 5, pp. 980-982
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top